CN110123921A - The preparation method and anti-dengue virus application of banana leaf extract - Google Patents
The preparation method and anti-dengue virus application of banana leaf extract Download PDFInfo
- Publication number
- CN110123921A CN110123921A CN201910478232.0A CN201910478232A CN110123921A CN 110123921 A CN110123921 A CN 110123921A CN 201910478232 A CN201910478232 A CN 201910478232A CN 110123921 A CN110123921 A CN 110123921A
- Authority
- CN
- China
- Prior art keywords
- banana
- banana leaf
- dengue virus
- dengue
- leaf extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000018290 Musa x paradisiaca Nutrition 0.000 title claims abstract description 50
- 241000700605 Viruses Species 0.000 title claims abstract description 23
- 208000001490 Dengue Diseases 0.000 title claims abstract description 21
- 206010012310 Dengue fever Diseases 0.000 title claims abstract description 21
- 208000025729 dengue disease Diseases 0.000 title claims abstract description 21
- 239000000284 extract Substances 0.000 title claims description 17
- 238000002360 preparation method Methods 0.000 title claims description 9
- 240000005561 Musa balbisiana Species 0.000 title 1
- 241000234295 Musa Species 0.000 claims abstract description 53
- 239000003814 drug Substances 0.000 claims abstract description 16
- 241000725619 Dengue virus Species 0.000 claims abstract description 12
- 239000000469 ethanolic extract Substances 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 5
- 238000002137 ultrasound extraction Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000010025 steaming Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 4
- 238000002474 experimental method Methods 0.000 abstract description 4
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 230000005764 inhibitory process Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- 239000002609 medium Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 230000000840 anti-viral effect Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 241001502567 Chikungunya virus Species 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 239000002154 agricultural waste Substances 0.000 description 2
- 235000021015 bananas Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 241000256118 Aedes aegypti Species 0.000 description 1
- 241000256173 Aedes albopictus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 201000009182 Chikungunya Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000291473 Musa acuminata Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- -1 cell culture plate Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000005727 virus proliferation Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明属于登革热病毒治疗技术领域,尤其涉及一种香蕉叶提取物的制备方法和抗登革热病毒应用。The invention belongs to the technical field of dengue fever virus treatment, and in particular relates to a preparation method of banana leaf extract and an anti-dengue virus application.
背景技术Background technique
病毒为自然界微生物的一种,按核酸类型分为DNA病毒和RNA病毒两种,其在自然界中分布广泛,可感染细菌、真菌、植物、动物和人,常引起宿主发病。由病毒引起的人患疾病很多,登革热(Dengue fever)为其中一种。Viruses are a kind of microorganisms in nature. They are divided into DNA viruses and RNA viruses according to the type of nucleic acid. They are widely distributed in nature and can infect bacteria, fungi, plants, animals and humans, and often cause disease in the host. People suffer from many diseases caused by viruses, and dengue fever (Dengue fever) is one of them.
登革热是由1~5型登革病毒(Dengue virus,DENV)引起并通过埃及伊蚊或白纹伊蚊叮咬传播的急性蚊媒传染病。该病流行往往呈暴发性,发病率高,但病死率较低,严重患者表现为血管渗透性增加、低血容量和凝血机制异常等,重症患者可导致死亡。该病主要发生在全世界热带和亚热带地区,近年来DF疫情呈上升趋势,WHO统计资料显示,全球约有25~40亿人受到DENV感染的威胁,估计每年发病达0.5~1亿例,全球近3亿人发生DENV隐性感染。目前全球发生DF疫情已有128个国家,DF在非洲、美洲、东地中海、东南亚和西太平洋100多个国家呈地方性流行,以美洲、东南亚和西太平洋地区更为严重,随着国际交流的深入,DF已成为全球严重的公共卫生问题。自1978年以来,我国由输入病例引起的DF暴发流行时有发生,广东、广西、云南、福建和河南等省均报告由输入病例引起的DF暴发,严重威胁着我国人民的健康生活。Dengue fever is an acute mosquito-borne infectious disease caused by dengue virus (DENV) types 1-5 and transmitted through the bite of Aedes aegypti or Aedes albopictus. The prevalence of the disease is often fulminant, with a high morbidity rate, but a low case fatality rate. Severe cases show increased vascular permeability, hypovolemia, and abnormal coagulation mechanisms. Severe cases can lead to death. The disease mainly occurs in tropical and subtropical regions of the world. In recent years, the DF epidemic has been on the rise. According to WHO statistics, about 2.5 to 4 billion people in the world are threatened by DENV infection. Nearly 300 million people have DENV recessive infection. At present, DF epidemics have occurred in 128 countries around the world. DF is endemic in more than 100 countries in Africa, the Americas, the Eastern Mediterranean, Southeast Asia and the Western Pacific, and it is more serious in the Americas, Southeast Asia and the Western Pacific. In-depth, DF has become a serious global public health problem. Since 1978, outbreaks of DF caused by imported cases have occurred frequently in my country. Guangdong, Guangxi, Yunnan, Fujian, Henan and other provinces have reported DF outbreaks caused by imported cases, which seriously threaten the healthy life of our people.
目前,登革热尚无疫苗可供预防,临床上还没有确切有效的病原治疗药物,只能以对症治疗为主,因此研究抗登革病毒药物为目前工作的重点。At present, there is no vaccine available for prevention of dengue fever, and there is no exact and effective pathogenic treatment drug in clinical practice, and only symptomatic treatment is given priority to. Therefore, research on anti-dengue virus drugs is the focus of current work.
香蕉(Musa nana Lour.)是芭蕉科芭蕉属多年生大型单子叶草本植物,广泛分布于南北纬30°以下的热带、亚热带地区。香蕉属高热量水果,果肉富含碳水化合物、蛋白质、脂肪、膳食纤维、多种微量元素以及维生素,为仅次于水稻、小麦和玉米的世界第四大粮食作物。大约有136个国家和地区生产香蕉,主产区集中在印度、菲律宾、中国、巴西等国。近年来,世界香蕉收获面积和产量均呈不断增长的趋势,在收获大量香蕉产品的同时也产生几乎等量的香蕉茎叶等农业废弃物。为此,如何对香蕉茎叶进行回收利用已成为一个亟待解决的课题。香蕉茎叶体积大,因而收集劳动强度高;含水量高,既不能直接燃烧又增加运输成本;但其本身具有较高的生物量,营养物质丰富,拥有巨大的开发潜力。目前大部分的香蕉茎秆、叶片等被用作饲料、肥料,或者用来生产低档纸、粗布、包装绳等产品,进一步则可发酵生产沼气或者酒精。而其药用价值的开发则鲜有报道,特别是用于抗病毒的研究则未见相关报道。Banana (Musa nana Lour.) is a perennial large-scale monocotyledonous herbaceous plant of the genus Musa in the Musa family. It is widely distributed in tropical and subtropical regions below 30° north and south latitude. Banana is a high-calorie fruit. The pulp is rich in carbohydrates, protein, fat, dietary fiber, various trace elements and vitamins. It is the fourth largest food crop in the world after rice, wheat and corn. About 136 countries and regions produce bananas, and the main production areas are concentrated in India, the Philippines, China, Brazil and other countries. In recent years, the harvested area and output of bananas in the world have shown a continuous growth trend. While harvesting a large number of banana products, almost the same amount of agricultural waste such as banana stems and leaves is produced. For this reason, how to recycle banana stems and leaves has become an urgent problem to be solved. Banana stems and leaves are bulky, so the collection labor intensity is high; the water content is high, which can neither be burned directly nor increase the transportation cost; but it has high biomass and rich nutrients, and has huge development potential. At present, most of the banana stems and leaves are used as feed, fertilizer, or used to produce low-grade paper, coarse cloth, packaging rope and other products, and further can be fermented to produce biogas or alcohol. However, there are few reports on the development of its medicinal value, especially for antiviral research.
发明内容Contents of the invention
本发明要解决的技术问题是提供一种香蕉叶提取物的制备方法和抗登革热病毒应用,以充分发掘废弃物香蕉叶的医药价值,为治疗登革热开辟中草药途径。The technical problem to be solved by the present invention is to provide a preparation method of banana leaf extract and anti-dengue fever virus application, so as to fully explore the medical value of waste banana leaves and open up a way of Chinese herbal medicine for the treatment of dengue fever.
为解决上述技术问题,本发明采用以下技术方案:In order to solve the problems of the technologies described above, the present invention adopts the following technical solutions:
香蕉叶提取物在制备抗登革热病毒药物中的应用。Application of banana leaf extract in preparation of anti-dengue virus medicine.
登革热病毒为登革2型病毒。Dengue virus is dengue type 2 virus.
香蕉叶提取物为香蕉叶的乙醇提取物。Banana leaf extract is the ethanol extract of banana leaves.
香蕉叶提取物的制备方法,取香蕉叶加乙醇超声提取,过滤,抽滤,滤液旋蒸回收溶剂至浓缩液状后,离心至干膏即得。The preparation method of the banana leaf extract comprises the following steps: taking banana leaves and adding ethanol for ultrasonic extraction, filtering, suction filtering, rotating the filtrate to recover the solvent to a concentrated liquid state, and centrifuging until the dry paste is obtained.
香蕉叶为香蕉叶绿色叶片部位鲜品。The banana leaf is a fresh product of the green leaf part of the banana leaf.
乙醇为体积浓度95%的乙醇,加入量为8倍香蕉叶重量。The ethanol is ethanol with a volume concentration of 95%, and the addition amount is 8 times of the banana leaf weight.
超声提取2h,旋蒸温度为40℃。Ultrasonic extraction was carried out for 2 hours, and the rotary steaming temperature was 40°C.
针对目前农作物废弃物香蕉叶价值尚未得到有效开发的问题,发明人经深入研究发现,香蕉叶的乙醇提取物具有一定的抑制登革病毒作用。据此,发明人还建立了香蕉叶乙醇提取物的相应提取方法。实验表明,香蕉叶乙醇提取物具有抗登革病毒效果,其对登革病毒IC50为3.79μg/ml。可见,香蕉叶具有抗登革热药物的潜在价值。因此,本发明为进一步开辟香蕉叶的医药应用提供了有力依据和可靠保障,可提高香蕉资源利用率,减少资源浪费;也为治疗登革热开辟了中草药途径,以降低药物生产成本。Aiming at the problem that the value of banana leaves, the agricultural wastes, has not been effectively exploited, the inventors have found through in-depth research that the ethanol extract of banana leaves has a certain inhibitory effect on dengue virus. Accordingly, the inventor has also established a corresponding extraction method of the banana leaf ethanol extract. Experiments show that the ethanol extract of banana leaves has anti-dengue virus effect, and its IC 50 against dengue virus is 3.79 μg/ml. It can be seen that banana leaves have the potential value of anti-dengue drugs. Therefore, the present invention provides a strong basis and reliable guarantee for further developing the medical application of banana leaves, which can improve the utilization rate of banana resources and reduce waste of resources; it also opens up a way of Chinese herbal medicine for the treatment of dengue fever, so as to reduce the cost of drug production.
附图说明Description of drawings
图1是本发明香蕉叶的乙醇提取物抗登革病毒空斑试验结果图。Fig. 1 is the result figure of the anti-dengue virus plaque test of the ethanol extract of banana leaf of the present invention.
图2是本发明香蕉叶的乙醇提取物抗基孔肯雅病毒空斑试验结果图。Fig. 2 is a graph showing the results of the anti-chikungunya virus plaque test of the ethanol extract of banana leaves of the present invention.
图3是本发明香蕉叶的乙醇提取物对登革病毒及基孔肯雅病毒抑制率结果图。Fig. 3 is the result chart of the inhibition rate of dengue virus and chikungunya virus by ethanol extract of banana leaves of the present invention.
具体实施方式Detailed ways
一、实验材料1. Experimental materials
1.香蕉叶提取物1. Banana Leaf Extract
取香蕉叶绿色叶片部位鲜品100.00g,加8倍量95%乙醇,超声提取2h,过滤后定性滤纸抽滤,取滤液置于旋转蒸发仪上40℃回收溶剂,至浓缩液状后,置于40℃离心浓缩,得787.40mg干膏备用。Take 100.00g fresh product from the green leaf part of banana leaf, add 8 times the amount of 95% ethanol, ultrasonically extract for 2 hours, filter and filter with qualitative filter paper, take the filtrate and put it on a rotary evaporator at 40°C to recover the solvent, until it is concentrated liquid, put it in Concentrate by centrifugation at 40°C to obtain 787.40 mg of dry paste for future use.
2.病毒株2. Virus strains
登革病毒、基孔肯雅病毒。Dengue virus, Chikungunya virus.
3.细胞株3. Cell lines
人肝癌细胞Huh-7、人宫颈癌细胞Hela、乳仓鼠肾细胞BHK21。Human liver cancer cells Huh-7, human cervical cancer cells Hela, and suckling hamster kidney cells BHK21.
4.主要试剂与仪器4. Main reagents and instruments
DMEM培养基、RPMI-1640培养基、FBS、Trypsin、alamar Blue、细胞培养板、DMSO、结晶紫溶液、离心浓缩仪、旋转蒸发仪、生物安全柜、CO2培养箱、移液枪、酶标仪。DMEM medium, RPMI-1640 medium, FBS, Trypsin, alamar Blue, cell culture plate, DMSO, crystal violet solution, centrifugal concentrator, rotary evaporator, biological safety cabinet, CO2 incubator, pipette gun, microplate reader .
二、实验方法2. Experimental method
1.药物细胞毒性试验1. Drug Cytotoxicity Test
(1)取对数生长期的Huh-7(Hela)肿瘤细胞适量至75ml培养瓶中,37℃培养至细胞生长状态良好,Trypsin消化细胞后按6.5×103个/孔(1.3×104个/孔)的细胞量接种于96孔板中,继续培养24h,备用。(1) Take an appropriate amount of Huh-7 (Hela) tumor cells in the logarithmic growth phase and put them in a 75ml culture flask, culture them at 37°C until the cells grow well, digest the cells with Trypsin at 6.5×10 3 cells/well (1.3×10 4 cells/well) were inoculated in a 96-well plate, continued to culture for 24 h, and were set aside.
(2)将各提取物用DMSO溶解之后,用含血清的DMEM培养基配制成药物浓度为100.00μg/ml、50.00μg/ml、25.00μg/ml、12.50μg/ml、6.25μg/ml的含药培养基,备用。0.1%DMSO作为溶剂对照。(2) After dissolving each extract with DMSO, use serum-containing DMEM medium to prepare drug concentrations of 100.00 μg/ml, 50.00 μg/ml, 25.00 μg/ml, 12.50 μg/ml, 6.25 μg/ml containing Medicine culture medium, spare. 0.1% DMSO was used as solvent control.
(3)取出已经培养24h的细胞,倾去96孔板中的培养基,加入含药物培养基,每个样品每个浓度设3个平行,另设模型组及溶剂对照组,模型组加入不含药培养基,溶剂对照组加入含0.1%DMSO的培养基,均设3个平行,继续37℃培养48h。(3) Take out the cells that have been cultured for 24 hours, discard the medium in the 96-well plate, add the medium containing the drug, set 3 parallels for each concentration of each sample, and set up a model group and a solvent control group separately. The drug-containing medium and the medium containing 0.1% DMSO were added to the solvent control group, and three parallel sets were set up, and culture was continued at 37°C for 48h.
(4)取出培养48h后的细胞,倾去培养基,均加入100μl(1:10配置)的alamar bule溶液,另取三个孔加入相同量的alamar blue溶液作为空白组,37℃孵育2h(以模型组颜色完全变化为粉红色为度),取出后于酶标仪(激发波长570nm,发射波长585nm)检测荧光度值。(4) Take out the cells cultured for 48 hours, discard the culture medium, add 100 μl (1:10 configuration) of alamar bule solution, add the same amount of alamar blue solution to another three wells as a blank group, and incubate at 37°C for 2 hours ( The color of the model group has completely changed to pink as the degree), and after taking it out, detect the fluorescence value in a microplate reader (excitation wavelength 570nm, emission wavelength 585nm).
计算公式为:(含药物组荧光度值平均值-空白组荧光度值平均值)/(模型组荧光度值平均值-空白组荧光度值平均值)×100%The calculation formula is: (the average value of the fluorescence value of the drug-containing group-the average value of the fluorescence value of the blank group)/(the average value of the fluorescence value of the model group-the average value of the fluorescence value of the blank group)×100%
2.抗病毒药效试验2. Antiviral efficacy test
(1)取培养至对数生长期的Huh-7(Hela)细胞,消化后按5×104个/孔(7×104个/孔)的量加至24孔板中,培养24h。(1) Huh-7 (Hela) cells cultured to the logarithmic growth phase were taken, digested and added to a 24-well plate at an amount of 5×10 4 cells/well (7×10 4 cells/well), and cultured for 24 hours.
(2)取出培养了24h的24孔板,倾去每个孔中的培养基。37℃水浴解冻DENV-2(CHIKV)病毒30s~1min,用DMEM培养基配制成含病毒为5×105PFU/ml(7×105PFU/ml)的稀释液,往每孔加入100μl病毒稀释液使接种于24孔板中每个孔的病毒单位为5×104PFU(7×104PFU),37℃孵育1h,取出后加PBS清洗两次。然后进行给药,香蕉叶提取物给药浓度参考细胞毒性实验中的安全浓度(给药后Huh-7/Hela细胞存活率≥80%),即为6.25μg/ml、12.50μg/ml、25.00μg/ml、50.00μg/ml。设三个平行孔,以0.1%DMSO为溶剂对照组,每孔给药体积1ml。37℃培养48h,培养结束后将每个孔中的培养基吸出装至1.5ml的离心管中做标记后,-80℃保存。(2) Take out the 24-well plate that has been cultured for 24 hours, and pour off the medium in each well. Thaw DENV-2 (CHIKV) virus in a water bath at 37°C for 30 seconds to 1 minute, prepare a virus-containing dilution of 5×10 5 PFU/ml (7×10 5 PFU/ml) with DMEM medium, and add 100 μl of virus to each well The dilution solution made the virus unit inoculated in each well of the 24-well plate 5×10 4 PFU (7×10 4 PFU), incubated at 37° C. for 1 hour, took it out, and washed it twice with PBS. Administration is then carried out, and the administration concentration of banana leaf extract refers to the safe concentration in the cytotoxicity experiment (Huh-7/Hela cell survival rate ≥ 80% after administration), which is 6.25 μg/ml, 12.50 μg/ml, 25.00 μg/ml, 50.00μg/ml. Three parallel wells were set up, 0.1% DMSO was used as the solvent control group, and the volume of administration in each well was 1 ml. Cultivate at 37°C for 48h, after the end of the culture, suck out the culture medium in each well and put it into a 1.5ml centrifuge tube for marking, then store at -80°C.
(3)取处于对数生长期的BHK21细胞,消化后按5×104个/孔的量加至24孔板中,每个流分每个浓度需要接种6孔,培养24h。培养结束后取出,倾倒培养基。取出(2)项下-80℃保存的含病毒样本,每个样品均需按10倍梯度稀释成6个浓度,分别为10-1、10-2、10-3、10-4、10-5、10-6,将每个稀释后的含病毒稀释液分别按100μl/孔的剂量加入至培养好的BHK21细胞中,37℃孵育1h,取出后加入PBS清洗两次,之后再加入培养基(1%CMC+2%FBS)1ml/孔。37℃培养6d(4d)。取出后倒去培养基,加入结晶紫溶液,摇床震摇过夜。倒去结晶紫溶液,清水清洗后擦干,进行空斑计数。(3) BHK21 cells in the logarithmic growth phase were taken, and after digestion, 5×10 4 cells/well were added to a 24-well plate. Each fraction and concentration needed to inoculate 6 wells, and cultured for 24 hours. After the cultivation, take it out and pour out the culture medium. Take out the virus-containing samples stored at -80°C under item (2), and each sample needs to be diluted into 6 concentrations according to a 10-fold gradient, which are 10 -1 , 10 -2 , 10 -3 , 10 -4 , 10 - 5 , 10 -6 , each diluted virus-containing dilution was added to the cultured BHK21 cells at a dose of 100 μl/well, incubated at 37°C for 1 hour, removed and washed twice with PBS, and then added to the culture medium (1% CMC+2% FBS) 1 ml/well. Incubate at 37°C for 6d (4d). After taking it out, pour out the medium, add crystal violet solution, and shake overnight on a shaker. Pour off the crystal violet solution, wash with water and dry, and count the plaques.
(4)取已擦干的24孔板,肉眼计数,记录空斑数量为1~20个之间的孔相应的空斑数,按给药组与对照组的总空斑数的对数值进行比较(总空斑数=肉眼空斑数×对应的稀释倍数×10),以对照组空斑数对数值的均值-给药组空斑数对数值的均值≥1为药物在该浓度下具有显著抗病毒作用,若1≥对照组空斑数对数值的均值-给药组空斑数对数值的均值≥0.5则表示药物在该浓度下具有抗病毒效果,同时根据抑制率计算IC50值。(4) Take the dried 24-well plate, count with the naked eye, record the number of plaques corresponding to the wells with 1 to 20 plaques, and perform the logarithm of the total number of plaques in the treatment group and the control group Comparison (total plaque number = naked eye plaque number × corresponding dilution factor × 10), the mean value of the logarithmic value of the plaque number in the control group - the mean value of the logarithmic value of the plaque number in the administration group ≥ 1 means that the drug has the effect at this concentration Significant antiviral effect, if 1 ≥ the mean value of the logarithmic value of the plaque number in the control group - the mean value of the logarithmic value of the plaque number in the treatment group ≥ 0.5, it means that the drug has an antiviral effect at this concentration, and the IC50 value is calculated based on the inhibition rate.
三、实验结果3. Experimental results
如图1至图3所示,香蕉叶提取物给药浓度大于或等于12.50μg/ml时具有抗病毒效果,给药浓度为50.00μg/ml时均能完全抑制病毒增殖,香蕉叶对登革病毒IC50为3.79μg/ml,对基孔肯雅病毒IC50为8.73μg/ml。As shown in Figures 1 to 3, banana leaf extract has an antiviral effect when the administration concentration is greater than or equal to 12.50 μg/ml, and can completely inhibit virus proliferation when the administration concentration is 50.00 μg/ml. The IC 50 of the virus was 3.79 μg/ml, and the IC 50 of Chikungunya virus was 8.73 μg/ml.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910478232.0A CN110123921B (en) | 2019-06-03 | 2019-06-03 | Preparation method of banana leaf extract and application of banana leaf extract in resisting dengue fever virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910478232.0A CN110123921B (en) | 2019-06-03 | 2019-06-03 | Preparation method of banana leaf extract and application of banana leaf extract in resisting dengue fever virus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110123921A true CN110123921A (en) | 2019-08-16 |
CN110123921B CN110123921B (en) | 2022-03-01 |
Family
ID=67579939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910478232.0A Active CN110123921B (en) | 2019-06-03 | 2019-06-03 | Preparation method of banana leaf extract and application of banana leaf extract in resisting dengue fever virus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110123921B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004083526A (en) * | 2002-08-28 | 2004-03-18 | Morinaga Milk Ind Co Ltd | Antiviral composition |
CN106336390A (en) * | 2016-08-25 | 2017-01-18 | 岑健 | Method for extracting flavone from banana leaves |
-
2019
- 2019-06-03 CN CN201910478232.0A patent/CN110123921B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004083526A (en) * | 2002-08-28 | 2004-03-18 | Morinaga Milk Ind Co Ltd | Antiviral composition |
CN106336390A (en) * | 2016-08-25 | 2017-01-18 | 岑健 | Method for extracting flavone from banana leaves |
Non-Patent Citations (1)
Title |
---|
MICHAEL D. SWANSON ETAL.: "A Lectin Isolated from Bananas Is a Potent Inhibitor of HIV Replication", 《THE JOURNAL OF BIOLOGICAL CHEMISTRY》 * |
Also Published As
Publication number | Publication date |
---|---|
CN110123921B (en) | 2022-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Knox et al. | Anti‐influenza virus activity of crude extract of Ribes nigrum L. | |
CN108926584A (en) | The antimicrobial purposes of chimonanthea extract | |
CN107737201A (en) | Lemna paucicostata antivirus action application | |
CN107260774A (en) | The purposes of wax-cakes bait Genes For Plant Tolerance pathogenic infection | |
CN110123921A (en) | The preparation method and anti-dengue virus application of banana leaf extract | |
CN104998022A (en) | Dragon's blood tree leaf extract product, and preparation method, pharmaceutical composition, preparation, and applications thereof | |
CN112274541A (en) | Application of semiliquidambar cathayensis or extract thereof in preparation of antitumor drugs | |
CN112402480A (en) | Preparation method and application of eucommia male flower extract with anti-fatigue effect | |
Su et al. | Antiviral activity and constituent of Ardisia chinensis benth against coxsackie B3 virus | |
CN110448623B (en) | Preparation method and anti-chikungunya virus application of banana leaf extract | |
CN102174095A (en) | Malania oleifera lectin and method for preparing same | |
CN104435062B (en) | A kind of blueberry wine mud extract for inducing apoptosis on hepatic stellate cells and its preparation technology and application | |
CN114668792A (en) | Extraction method and application of paper mulberry extract | |
CN106421722A (en) | Traditional Chinese medicine composition and application thereof | |
CN106177035B (en) | Preparation method and application of effective rosa chinensis flower extract with blood sugar reducing and anticancer functions | |
CN113662974A (en) | A kind of preparation and purification method of rhombohedral polyphenol extract | |
CN107050053A (en) | A kind of Contained Serum prepared by Ligusticum wallichii alcohol extract and its preparation method and application | |
CN105998083A (en) | Arenobufagin extraction method and arenobufagin product | |
CN113181229B (en) | Application of cabbage type rape-isatis tinctoria G monomer addition system in inhibiting novel coronavirus SARS-CoV-2 | |
Singh et al. | Phytochemical Analysis and Antimicrobial Activity of Various Indigenous Plant Species | |
CN118453735B (en) | Tibetan medicine formula for resisting porcine pseudorabies virus and preparation method thereof | |
CN102318651B (en) | Nematicidal extract of radix-polygoni multiflori and preparation method thereof | |
CN107296840B (en) | Cape jasmine and fermented soybean soup effective part and application thereof in preparation of neuroprotective drugs | |
CN107115370B (en) | The purposes of the anti-enterovirus of wintersweet platymiscium | |
CN1883530B (en) | Laggera extracts with anti-virus, anti-inflammation and/or antibiotic functions and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |